Skip to main content

Peer Review reports

From: Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study)

Original Submission
15 Mar 2021 Submitted Original manuscript
23 Mar 2021 Author responded Author comments - Yujiro Nishizawa
Resubmission - Version 2
23 Mar 2021 Submitted Manuscript version 2
29 Mar 2021 Reviewed Reviewer Report
10 Apr 2021 Reviewed Reviewer Report - Yusuf Acikgoz
11 Apr 2021 Reviewed Reviewer Report
23 Apr 2021 Reviewed Reviewer Report
31 Jul 2021 Author responded Author comments - Yujiro Nishizawa
Resubmission - Version 3
31 Jul 2021 Submitted Manuscript version 3
4 Aug 2021 Reviewed Reviewer Report
4 Aug 2021 Reviewed Reviewer Report
8 Aug 2021 Reviewed Reviewer Report - Yusuf Acikgoz
12 Aug 2021 Author responded Author comments - Yujiro Nishizawa
Resubmission - Version 4
12 Aug 2021 Submitted Manuscript version 4
Publishing
16 Aug 2021 Editorially accepted
23 Aug 2021 Article published 10.1186/s12885-021-08690-y

You can find further information about peer review here.

Back to article page